Preparation and Evaluation of Oroslippery Tablets Contain Irbesartan and Hydrochlorothiazide Combination for Dysphagia Patients

• Main Authors: Yasir Q. almajidi (Author), Yaseen T. Khalaf (Author), Naeem M. Shalan (Author), Israa H. Alani (Author), Wael A. Abu Dayyih (Author)
• Format: Book
• Published: College of Pharmacy University of Baghdad, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Oro slippery tablets (OSTs) is a technique used to improve swallowing of tablets for patients with dysphagia. The aim of this study was to formulate irbesartan and hydrochlorothiazide as Oroslippery tablets (OST) containing 150 mg irbesartan and 25 mg hydrochlorothiazide for dysphagia patients. A si...